A panel examines the expansion of GLP-1 medications beyond weight loss, exploring new medical uses, potential side effects and what the next wave of these blockbuster drugs could mean for patients on ‘Barron’s Roundtable.’
A panel examines the rapid expansion of GLP-1 medications beyond weight loss, discussing how the drugs are being studied for a growing range of conditions, the potential risks and side effects associated with their use, and what the next generation of these blockbuster treatments could mean for patients, the stock and the pharmaceutical industry on ‘Barron’s Roundtable.’
Read the full article here